Trexquant Investment’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.21M | Buy |
+50,663
| New | +$2.21M | 0.02% | 852 |
|
|
2024
Q3 | – | Sell |
-117,328
| Closed | -$3.5M | – | 1718 |
|
|
2024
Q2 | $3.5M | Sell |
117,328
-44,787
| -28% | -$1.34M | 0.05% | 518 |
|
|
2024
Q1 | $6.52M | Sell |
162,115
-41,449
| -20% | -$1.67M | 0.13% | 220 |
|
|
2023
Q4 | $5.18M | Buy |
+203,564
| New | +$5.18M | 0.12% | 240 |
|
|
2022
Q1 | – | Sell |
-10,454
| Closed | -$664K | – | 1560 |
|
|
2021
Q4 | $664K | Buy |
+10,454
| New | +$664K | 0.04% | 526 |
|
|
2021
Q2 | – | Sell |
-6,380
| Closed | -$248K | – | 1313 |
|
|
2021
Q1 | $248K | Buy |
+6,380
| New | +$248K | 0.02% | 856 |
|